A quality network model for the daily care of multiple sclerosis

Multiple Sclerosis

Volumn 6, Issue 4, 2000, Pages 231-236

  Blumhardt, L D ^a   Vermeij, B J D ^a   Amato, M ^a   Andersen, O ^a   Edan, G ^a   Fernandez, O ^a   Filippi, M ^a   Haas, J ^a   Hommes, O R ^a   Rieckmann, P ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Epidemiology; Multiple sclerosis; Outcome measures; Quality network

Indexed keywords

ALGORITHM; ARTICLE; COMPUTER NETWORK; EPIDEMIOLOGICAL DATA; HEALTH CARE MANAGEMENT; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HUMAN; MEDICAL AUDIT; MEDICAL DECISION MAKING; MULTIPLE SCLEROSIS; QUALITY CONTROL; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0033849455     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/135245800678827842     Document Type: Article

References (21)

1. Harvesting knowledge from improvement
2. Variation in medical practice and hospital costs
3. A new learning environment: Combining clinical research with quality improvement
4. Report van Diabcare Thinkshop Quality Network Diabetes
5. Qualitatsmanagement
6. The PACE (population-adjusted clinical epidemiology) strategy: A new approach to multi-centred clinical research
7. Benchmarking en Diabetes Management
8. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial
9. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis
10. Dose-dependent clinical and magnetic resonance imaging efficacy of interferon beta-1a (Rebif(R)) in multiple sclerosis
11. Placebo-controlled multi-centre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis
12. Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis
13. Results of the 3-year, double-blind, placebo-controlled, study of interferon beta-1a (Rebif) in secondary-progressive MS. Presented at the Ninth Meeting of the European Neurological Society, 5th June 1999, Milan, Italy
14. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: Results of a phase III multicentre, double-blind, placebo-controlled trial
15. Nice Declaration, Scoring and Databasing in Multiple Sclerosis. Proceedings of the European Charcot Foundation Symposium
16. The Guy's Neurological Disability Scale (GNDS): A new disability measure for multiple sclerosis
17. A new approach to the measurement of the quality of life: A patient generated index
18. The functional status of patients: How can it be measured in physicians' offices?
19. Assessment of function in routine clinical practice: Description of the COOP chart method and preliminary findings
20. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)